Literature DB >> 2481242

Serotonin release estimated by transcortical dialysis in freely-moving rats.

E Carboni1, G Di Chiara.   

Abstract

The transcerebral dialysis method has been utilized for measuring extracellular brain concentrations of serotonin and 5-hydroxyindolacetic acid. Dialysis fibres were implanted transversally in the rat frontal cortex and perfused by Ringer. Serotonin and 5-hydroxyindolacetic acid were quantified by reverse phase high performance liquid chromatography with electrochemical detection. Experiments were performed in freely-moving rats 20-24 h after the implant of the fibre. Basal output of serotonin and 5-hydroxyindolacetic acid was 0.12 and 22.8 pmol in 20 min, respectively. The output of serotonin was calcium-dependent and tetrodotoxin-sensitive (1 micron in the Ringer) while was stimulated by veratridine (50 microns) and by high concentrations of K+ (60 and 100 mM). Serotonin output was increased in a concentration-dependent manner by chlorimipramine (1-10 microM) in the Ringer; this drug stimulated serotonin release also when administered s.c. (20 mg/kg) in a tetrodotoxin-sensitive manner. The irreversible monoamine-oxidase inhibitor pargyline (75 mg/kg, i.p.) strongly stimulated serotonin output while reduced 5-hydroxyindolacetic acid output. A proposed serotonin releaser, fenfluramine (25 mg/kg, s.c.), stimulated serotonin release and this effect was strongly potentiated by local application of tetrodotoxin (1 microM). Agonists of serotonin receptors such as lisuride (0.03 mg/kg, s.c.), 8-hydroxy-2-(di-n-propilamino)tetraline (0.25 mg/kg, s.c.) and 5-methoxy 3(1,2,3,6-tetrahydro-4-pyridinil)-1H indole succinate (1 mg/kg, s.c.) reduced serotonin release. It appears that brain dialysis is a suitable method for the study of serotonin release in the cortex of freely-moving rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481242     DOI: 10.1016/0306-4522(89)90285-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex.

Authors:  G Tanda; R Frau; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.

Authors:  P Celada; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

4.  In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.

Authors:  N Bel; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

5.  Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

Authors:  P Hertel; G G Nomikos; M Iurlo; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

6.  Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.

Authors:  J Ortiz; F Artigas
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

7.  Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.

Authors:  N M Barnes; C H Cheng; B Costall; J Ge; R J Naylor
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.

Authors:  T Mennini; A Bizzi; S Caccia; A Codegoni; C Fracasso; E Frittoli; G Guiso; I M Padura; C Taddei; A Uslenghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

9.  Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

Authors:  U Freo; H W Holloway; N H Greig; T T Soncrant
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin.

Authors:  M Gobbi; E Frittoli; T Mennini; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.